Endocan and Major Adverse Cardiovascular Events: Understanding Regression Methods

被引：1
|
作者：
Aksu, Ugur [1 ]
Gulcu, Oktay [1 ]
Aksakal, Emrah [1 ]
Kalkan, Kamuran [1 ]
机构：
[1] Erzurum Training & Res Hosp, Dept Cardiol, Erzurum, Turkey
来源：
ANGIOLOGY | 2019年 / 70卷 / 10期
关键词：
endocan; mortality; myocardial infarction;
D O I：
10.1177/0003319719828911
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：982 / 982
页数：1
相关论文
共 50 条
  • [21] Risk of Major Adverse Cardiovascular Events in Patients With Rheumatoid Arthritis
    Mal, Kheraj
    Kumar, Ratan
    Mansoor, Farah
    Kaur, Navneet
    Kumar, Anil
    Memon, Sidra
    Rizwan, Amber
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (12)
  • [22] Association of Prior Intracerebral Hemorrhage With Major Adverse Cardiovascular Events
    Gaist, David
    Hald, Stine Munk
    Garcia Rodriguez, Luis Alberto
    Clausen, Anne
    Moller, Soren
    Hallas, Jesper
    Salman, Rustam Al-Shahi
    JAMA NETWORK OPEN, 2022, 5 (10) : E2234215
  • [23] Association of chronic venous disease with major adverse cardiovascular events
    Singh, Tejas P.
    Velu, Ramesh B.
    Quigley, Frank
    Golledge, Jonathan
    JOURNAL OF VASCULAR SURGERY-VENOUS AND LYMPHATIC DISORDERS, 2022, 10 (03) : 683 - 688
  • [24] RISK OF MAJOR ADVERSE CARDIOVASCULAR EVENTS ACCORDING TO DIALYSIS MODALITY
    Bitar, Wisam
    Helve, Jaako
    Haapio, Mikko
    Rauta, Virpi
    Honkanen, Eero Olavi
    Finne, Patrik
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 : I64 - I64
  • [25] Anticoagulation for VTE Impact on the Risk of Major Adverse Cardiovascular Events
    Noumegni, Steve Raoul
    Le Mao, Raphael
    de Moreuil, Claire
    Hoffmann, Clement
    Le Moigne, Emmanuelle
    Tromeur, Cecile
    Mansourati, Vincent
    Nasr, Bahaa
    Gentric, Jean-Christophe
    Guegan, Marie
    Poulhazan, Elise
    Bressollette, Luc
    Lacut, Karine
    Didier, Romain
    Couturaud, Francis
    CHEST, 2022, 162 (05) : 1147 - 1162
  • [26] Predictors of Major Adverse Cardiovascular Events by Combining Clinical Data with Non-Invasive Screening Methods
    Ozhan, Hakan
    Albayrak, Sinan
    Turker, Yasin
    Aslantas, Yusuf
    Ekinozu, Ismail
    Tibilli, Hakan
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 62 (18) : C112 - C112
  • [27] ASSOCIATION OF ENDOCAN LEVEL AND OBESITY WITH THE DEVELOPMENT OF CARDIOVASCULAR EVENTS
    Baidildina, B.
    Turgunova, L.
    Turmukhambetova, A.
    Laryushina, Y.
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2022, 128 : S54 - S54
  • [28] Risk Factors for Major Adverse Cardiovascular Events and Major Adverse Limb Events after Venous Thromboembolism: A Large Prospective Cohort Study
    Noumegni, Steve Raoul
    Didier, Romain
    Mansourati, Vincent
    Le Moigne, Emmanuelle
    Le Mao, Raphael
    Hoffmann, Clement
    Moreuil, Claire De
    Tromeur, Cecile
    Le Roux, Pierre-Yves
    Nasr, Bahaa
    Gentric, Jean-Christophe
    Guegan, Marie
    Poulhazan, Elise
    Lacut, Karine
    Bressollette, Luc
    Couturaud, Francis
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2022, 48 (04): : 465 - 480
  • [29] IMPACT OF ANTIDEPRESSANTS ON RISK FOR MAJOR ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS WITH AND WITHOUT CARDIOVASCULAR DISEASE
    Lavoie, Kim L.
    Paine, Nicola J.
    Pelletier, Roxanne
    Arsenault, Andre
    Campbell, Tavis
    Pilote, Louise
    Bacon, Simon L.
    Diodati, Jean G.
    ANNALS OF BEHAVIORAL MEDICINE, 2017, 51 : S1737 - S1738
  • [30] Lipoprotein(a) and Major Adverse Cardiovascular Events in Patients With or Without Baseline Atherosclerotic Cardiovascular Disease
    Berman, Adam N.
    Biery, David W.
    Besser, Stephanie A.
    Singh, Avinainder
    Shiyovich, Arthur
    Weber, Brittany N.
    Huck, Daniel M.
    Divakaran, Sanjay
    Hainer, Jon
    Kaur, Gurleen
    Blaha, Michael J.
    Cannon, Christopher P.
    Plutzky, Jorge
    Januzzi, James L.
    Booth, John N.
    Lopez, J. Antonio G.
    Kent, Shia T.
    Nasir, Khurram
    Carli, Marcelo F. Di
    Bhatt, Deepak L.
    Blankstein, Ron
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (09) : 873 - 886
12345